Skip to main content
. 2024 Apr;74(2):81–91. doi: 10.30802/AALAS-CM-23-000069

Figure 3.


Figure 3.

Outcome parameters by sex and alfaxalone-midazolam (AM) mixtures: (A) steady-state minute volume (SSMV); (B) accumulated minute volume (AMV) by sex and alfaxalone-midazolam (AM) mixture; (C) side effects scores and body condition scores (BCS); (D) Duration of anesthesia. Scatter plot values have been displaced slightly or “jittered” to make the entries more visible to the reader.